Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
JAMA Cardiol ; 9(3): 303, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38231492

ABSTRACT

This case report discusses a diagnosis of pulmonary arteriovenous fistulas in a female patient in her 30s who presented with a 5-year history of hypoxia, syncope, and headaches.


Subject(s)
Headache , Syncope , Humans , Female
3.
Nat Prod Res ; : 1-7, 2023 Apr 12.
Article in English | MEDLINE | ID: mdl-37042679

ABSTRACT

Three undescribed coumarins, 6-(3-hydroxy-3-methyl-2-oxobutyl)-7-methoxycoumarin (1), (R)-6-(1,3-dihydroxy-3-methyl-2-oxobutyl)-7-methoxycoumarin (2), angelol N (6), together with four known coumarins were isolated from the roots of Angelica pubescens. Their structures were determined by extensive spectroscopic analyses. The absolute configurations of compounds 2 and 6 were assigned via electronic circular dichroism (ECD). Their inhibitory effects on lipopoly-saccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 cells were evaluated. Compounds 1-4 exhibited moderate inhibitory activities.

4.
Int Urol Nephrol ; 55(2): 367-376, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35941302

ABSTRACT

PURPOSE: Acute kidney injury (AKI) induced by renal ischaemia/reperfusion (I/R) during renal transplantation has been reported to be linked to the regulation of SIRT2, one of the members of SIRTUINS family. Current work is attempted to explore the influence and mechanism of SIRT7 in renal cell apoptosis controlled by miR-152-3p during renal I/R injury. METHODS: Three databases were used to select the miRNAs regulating the expression of SIRT7. Overexpression and inhibition of miR-152-3p and Luciferase assay were employed to certify the modulation of miR-152-3p to SIRT7 in cells. RT-qPCR assay was used to measure the mRNA levels. Western blot assay was employed to determine the expression of proteins. TUNEL assay and Flow Cytometry were conducted to analyze cell apoptosis. RESULTS: SIRT7 expression decreased in tissues of AKI patients and rats underwent renal I/R, which was associated with enhanced impairment of renal function. SIRT7 downregulation was attributed to the direct inhibition by miR-152-3p due to binding and inhibiting its seed sequence in 3'-UTR of SIRT7 mRNA. Consequently, the upregulation of miR-152-3p led to an inhibition of SIRT7 expression, an increase in expression of extrinsic apoptosis molecules containing FOXO3a, Bim, and caspase3, and apoptotic renal cells; while miR-152-3p inhibition abolished these phenotypes. CONCLUSION: SIRT7 downregulation by miR-152-3p is a leading cause of renal cell apoptosis and functional impairment induced by renal I/R. Inhibition of miR-152-3p to restore SIRT7 expression can be a promising strategy against renal I/R injury.


Subject(s)
Acute Kidney Injury , MicroRNAs , Reperfusion Injury , Sirtuins , Rats , Animals , Reperfusion Injury/complications , Reperfusion Injury/genetics , Reperfusion Injury/metabolism , MicroRNAs/genetics , MicroRNAs/metabolism , Kidney/metabolism , Apoptosis/genetics , Acute Kidney Injury/genetics , RNA, Messenger , Sirtuins/genetics
5.
Mutagenesis ; 36(4): 281-293, 2021 08 27.
Article in English | MEDLINE | ID: mdl-34132814

ABSTRACT

Poly (ADP-ribose) polymerase-1 (PARP1), a DNA repair gene, is the crucial player in the maintenance of genome integrity. T2285C polymorphism in coding region of PARP1 has been reported to be associated with susceptibility to tumours. We explored the relationship and mechanism of T2285C polymorphism of PARP1 to its expression and activity along with risk and prognosis in non-small cell lung cancer (NSCLC). mRNA expression was measured using quantitative RT-PCR assay or collected from TCGA dataset. Protein expression was examined with immunoblotting assay. Genotypes were determined by PCR-RFLP and sequencing approaches. PARP1 activity was determined with enzyme activity assay. Regulation of SIRT7 to PARP1 was determined by overexpression and small interference experiment. Association of PARP1 T2285C polymorphism with NSCLC risk was evaluated via multiple logistic regression analysis. Comparison of treatment response and progression-free survival (PFS) of NSCLC patients among different genotypes or regimens was made by chi-square test. Results indicated that mRNA and protein expression of PARP1 dramatically increased in NSCLC tissues in comparison with paired para-carcinoma tissues (P < 0.05). TC/CC mutant genotypes were associated with markedly enhanced PARP1 mRNA level compared with TT genotype (P = 0.011). No significant difference was discovered in PARP1 protein expression among TT, TC or CC genotypes (P > 0.05). Subjects with variant allele C had higher risk of NSCLC in comparison with allele T carriers [odds ratio = 1.560; P = 0.000]. NSCLC patients carrying mutational TC or CC genotypes were correlated with unfavourable response to platinum-based chemotherapy (TT vs. TC vs. CC, P = 0.010), and shorter PFS compared with TT genotype (TT vs. TC vs. CC, P = 0.009). T2285C mutation of PARP1 resulted in the enhancement of its mRNA, but the decrease of enzyme activity in tumour cell. Overexpression of SIRT7 attenuated PARP1 expression and activity. These findings suggest the variant allele C of T2285C polymorphism of PARP1 linked to an increase of NSCLC risk, and unfavourable efficacy and prognosis of NSCLC patients with platinum-based chemotherapy, which might be associated with enhancement of its mRNA expression and the diminishment of activity. Identification of PARP1 T2285C polymorphism and mRNA expression may be the promising way for the individualised treatment of NSCLC.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Non-Small-Cell Lung/genetics , Lung Neoplasms/genetics , Poly (ADP-Ribose) Polymerase-1/genetics , Polymorphism, Single Nucleotide , Aged , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/enzymology , Carcinoma, Non-Small-Cell Lung/epidemiology , Female , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/enzymology , Lung Neoplasms/epidemiology , Male , Middle Aged , Poly (ADP-Ribose) Polymerase-1/metabolism , Prognosis , Risk , Sirtuins
6.
Sci Rep ; 10(1): 19446, 2020 Nov 04.
Article in English | MEDLINE | ID: mdl-33149142

ABSTRACT

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

7.
Sci Rep ; 7(1): 9155, 2017 08 22.
Article in English | MEDLINE | ID: mdl-28831132

ABSTRACT

Leaves of Cyclocarya paliurus are a sweet tea traditionally used to treat obesity and diabetes in China. However, its protective mechanisms against hyperglycemia remains unclear. Here, we demonstrate that the extract of C. paliurus leaves significantly decreased body loss, food intake and blood glucose level, and increased blood insulin level, ß-cell number and insulin-producing ß cells in high-fat diet-low dose STZ-induced diabetic mice. In vivo and in vitro studies also showed the extract of C. paliurus leaves significantly inhibited pancreatic ß cell apoptosis by suppressing the expression of caspase 8, caspase 9 and cleaved caspase-3, as well as Bax/Bcl-2 ratio, down-regulating p38, ERK and JNK phosphorylation, and up-regulating Akt phosphorylation. These effects were significantly enhanced by inhibitor p-38 or ERK or JNK, and counteracted by inhibitor of PI3K. In addition, the extract of C. paliurus leaves also significantly improved hepatic steatosis, nephropathy and cardiac hypertrophy of diabetic mice. Taken together, these results provide the insight into the effects of C. paliurus leaves on pancreatic ß cell preservation in standing glucolipotoxicity. Therefore, C. paliurus tea leaves may be used as a new remedy for diabetes through enhancing pancreatic ß cell preservation by inhibiting ß cell apoptosis.


Subject(s)
Cardiomegaly/drug therapy , Diabetes Mellitus, Experimental/drug therapy , Diabetic Nephropathies/drug therapy , Fatty Liver/drug therapy , Insulin-Secreting Cells/cytology , Juglandaceae/chemistry , Plant Extracts/administration & dosage , Animals , Apoptosis/drug effects , Blood Glucose/drug effects , Cardiomegaly/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetic Nephropathies/metabolism , Diet, High-Fat/adverse effects , Eating/drug effects , Fatty Liver/metabolism , Gene Expression Regulation/drug effects , Insulin/blood , Insulin-Secreting Cells/drug effects , Mice , Plant Extracts/pharmacology , Plant Leaves/chemistry , Signal Transduction/drug effects , Streptozocin
8.
Molecules ; 22(7)2017 Jul 20.
Article in English | MEDLINE | ID: mdl-28726741

ABSTRACT

Magnolol is a lignan with anti-inflammatory activity identified in Magnolia officinalis. Ulcerative colitis (UC), one of the types of inflammatory bowel disease (IBD), is a disease that causes inflammation and ulcers in the colon. To investigate the effect of magnolol in dextran sulfate sodium (DSS)-induced experimental UC model, male C57 mice were treated with 2% DSS drinking water for 5 consecutive days followed by intragastric administration with magnolol (5, 10 and 15 mg/kg) daily for 7 days. The results showed that magnolol significantly attenuated disease activity index, inhibited colonic shortening, reduced colonic lesions and suppressed myeloperoxidase (MPO) activity. Moreover, colonic pro-inflammatory cytokines (TNF-α, IL-6, and IL-1ß) induced by colitis were dramatically decreased by magnolol. To further unveil the metabolic signatures upon magnolol treatment, mass spectrometry-based metabolomic analysis of the small molecular metabolites in mice serum were performed. Compared with controls, abnormality of serum metabolic phenotypes in DSS-treated mice were effectively reversed by different doses of magnolol. In particular, magnolol treatment effectively elevated the serum levels of tryptophan metabolites including kynurenic acid (KA), 5-hydroxyindoleacetic acid, indoleacetic acid (IAA), indolelactic acid and indoxylsulfuric acid, which are potential aryl hydrocarbon receptor (AHR) ligands to impact colitis. These findings suggest that magnolol exerts anti-inflammatory effect on DSS-induced colitis and its underlying mechanisms are associated with the restoring of tryptophan metabolites that inhibit the colonic inflammation.


Subject(s)
Biphenyl Compounds/therapeutic use , Colitis/chemically induced , Colitis/drug therapy , Dextran Sulfate/toxicity , Lignans/therapeutic use , Polyphenols/therapeutic use , Animals , Colitis/blood , Indoleacetic Acids/blood , Indoles/blood , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Kynurenic Acid/blood , Male , Mice , Mice, Inbred C57BL , Tumor Necrosis Factor-alpha/metabolism
9.
Front Pharmacol ; 8: 277, 2017.
Article in English | MEDLINE | ID: mdl-28567017

ABSTRACT

Recent studies indicate that mitochondrial pathways of apoptosis are potential chemotherapeutic target for the treatment of esophageal cancer. Azoxystrobin (AZOX), a methoxyacrylate derived from the naturally occurring strobilurins, is a known fungicide acting as a ubiquinol oxidation (Qo) inhibitor of mitochondrial respiratory complex III. In this study, the effects of AZOX on human esophageal squamous cell carcinoma KYSE-150 cells were examined and the underlying mechanisms were investigated. AZOX exhibited inhibitory effects on the proliferation of KYSE-150 cells with inhibitory concentration 50% (IC50) of 2.42 µg/ml by 48 h treatment. Flow cytometry assessment revealed that the inhibitory effect of AZOX on KYSE-150 cell proliferation occurred with cell cycle arrest at S phase and increased cell apoptosis in time-dependent and dose-dependent manners. Cleaved poly ADP ribose polymerase (PARP), caspase-3 and caspase-9 were increased significantly by AZOX. It is worth noted that the Bcl-2/Bax ratios were decreased because of the down-regulated Bcl-2 and up-regulated Bax expression level. Meanwhile, the cytochrome c release was increased by AZOX in KYSE-150 cells. AZOX-induced cytochrome c expression and caspase-3 activation was significantly blocked by Bax Channel Blocker. Intragastric administration of AZOX effectively decreased the tumor size generated by subcutaneous inoculation of KYSE-150 cells in nude mice. Consistently, decreased Bcl-2 expression, increased cytochrome c and PARP level, and activated caspase-3 and caspase-9 were observed in the tumor samples. These results indicate that AZOX can effectively induce esophageal cancer cell apoptosis through the mitochondrial pathways of apoptosis, suggesting AZOX or its derivatives may be developed as potential chemotherapeutic agents for the treatment of esophageal cancer.

10.
Mol Biosyst ; 12(7): 2296-303, 2016 06 21.
Article in English | MEDLINE | ID: mdl-27197570

ABSTRACT

Hypoxia and inflammation have been identified as the hallmarks of colitis, intertwined with metabolism. Here, we report that halofuginone (HF), an antiparasitic drug, attenuates dextran sulfate sodium (DSS)-induced colitis in mice, as represented by attenuating the disease activity index, inhibiting colonic shortening, ameliorating colonic lesions and histological signs of damage, reducing colonic myeloperoxidase activity, and suppressing the production of pro-inflammatory cytokines in colon tissue. Intriguingly, the hypoxia-inducible factor 1alpha (HIF-1α) and tumor necrosis factor alpha were also suppressed by HF treatment in colon tissues, exhibiting a tissue-specific effect. To further reveal the metabolic signatures upon HF treatment, mass spectrometry-based metabolomic analysis of the small molecular metabolites in liver, spleen and colon tissues was performed. As a result, we found that HF treatment counteracted the levels of acylcarnitines, including palmitoyl-l-carnitine, isobutyrylcarnitine, vaccenylcarnitine, and myristoylcarnitine, in colon tissues with DSS induction, but no significant change in the levels of acylcarnitines was observed in liver or spleen tissues. The metabolic signatures may indicate that incomplete fatty acid oxidation (FAO) in the colon could be restored upon HF treatment as the tissue-specific metabolic characterization. Taken together, our findings uncovered that the HF potentiated anti-inflammatory effect in DSS-induced colitis in mice and its underlying mechanisms could be associated with the inhibition of HIF-1α and reduced levels of acylcarnitines, suggesting that both the inhibition of HIF-1α and the counteraction of incomplete FAO might be useful in the prevention and treatment of inflammatory bowel disease.


Subject(s)
Colitis/metabolism , Energy Metabolism/drug effects , Piperidines/pharmacology , Quinazolinones/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Biomarkers , Body Weight/drug effects , Colitis/chemically induced , Colitis/drug therapy , Colitis/pathology , Cytokines/metabolism , Dextran Sulfate/adverse effects , Disease Models, Animal , Enzyme Activation/drug effects , Fatty Acids/metabolism , Gene Expression , Hypoxia/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Inflammation Mediators/metabolism , Liver/metabolism , Male , Metabolic Networks and Pathways/drug effects , Mice , Models, Biological , Oxidation-Reduction/drug effects , Peroxidase/metabolism , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Spleen/metabolism
11.
Pharmacol Res ; 110: 227-239, 2016 08.
Article in English | MEDLINE | ID: mdl-26969793

ABSTRACT

Ulcerative colitis (UC) is an increasingly common condition particularly in developed countries. The lack of satisfactory treatment has fueled the search for alternative therapeutic strategies. In recent studies, berberine, a plant alkaloid with a long history of medicinal use in Chinese medicine, has shown beneficial effects against animal models of acute UC. However, UC usually presents as a chronic condition with frequent relapse in patients. How berberine will act on chronic UC remains unclear. In the present study, we adopted dextran sulfate sodium (DSS)-induced chronic relapsing colitis model to assess the ameliorating activity of berberine. Colitis was induced by two cycles of 2.0% DSS for five days followed by 14days of drinking water plus a third cycle consisting of DSS only for five days. The colitis mice were orally administered 20mg/kg berberine from day 13 onward for 30days and monitored daily. The body weight, stool consistency, and stool bleeding were recorded for determination of the disease activity index (DAI). At the end of treatment, animals were sacrificed and samples were collected and subjected to histological, RT-qPCR, Western blot, and LC-MS analyses. Lymphocytes were isolated from spleens and mesenteric lymph nodes (MLN) and cultured for flow cytometry analysis of IL-17 secretion from CD4(+) cells and the Th17 cell differentiation. Results showed that berberine significantly ameliorated the DAI, colon shortening, colon tissue injury, and reduction of colonic expression of tight junction (TJ) protein ZO-1 and occludin of colitis mice. Notably, berberine treatment pronouncedly reduced DSS-upregulated Th17-related cytokine (IL-17 and ROR-γt) mRNAs in the colon. Furthermore, the mRNA expression of IL-6 and IL-23, and the phosphorylation of STAT3 in colon tissues from DSS-treated mice were pronouncedly inhibited by berberine. Moreover, the up-regulation of IL-17 secretion from CD4(+) cells of spleens and MLNs caused by DSS were significantly reversed by berberine treatment. Furthermore, Th17 cell differentiation from naive CD4(+) cells isolated from above DSS colitis mice were suppressed by berberine in a concentration-dependent manner. In summary, we demonstrated for the first time that berberine reduced the severity of chronic relapsing DSS-induced colitis by suppressing Th17 responses. The demonstration of activity in this mouse model supports the possibility of clinical efficacy of berberine in treating chronic UC.


Subject(s)
Berberine/pharmacology , Colitis/drug therapy , Colon/drug effects , Dextran Sulfate , Gastrointestinal Agents/pharmacology , Interleukin-17/metabolism , Th17 Cells/drug effects , Animals , Cells, Cultured , Chronic Disease , Colitis/chemically induced , Colitis/immunology , Colitis/metabolism , Colon/immunology , Colon/metabolism , Colon/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Immunosuppressive Agents/pharmacology , Interleukin-17/genetics , Interleukin-17/immunology , Interleukin-23/genetics , Interleukin-23/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Mice, Inbred C57BL , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , Phenotype , Phosphorylation , RNA, Messenger/genetics , RNA, Messenger/metabolism , Recurrence , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Th17 Cells/immunology , Th17 Cells/metabolism , Time Factors
12.
J Nat Prod ; 79(4): 1056-62, 2016 Apr 22.
Article in English | MEDLINE | ID: mdl-26905227

ABSTRACT

The immunoregulatory protective properties of (+)-3'α-angeloxy-4'-keto-3',4'-dihydroseselin (Pd-Ib) isolated from Bupleurum malconense has not been reported. In the present study, the therapeutic effect of Pd-Ib (30, 60, and 120 mg/kg/day) was examined in a mouse model of dextran sulfate sodium (DSS)-induced acute colitis. Administration of Pd-Ib significantly reduced the disease activity index, inhibited the shortening of colon length, reduced colonic tissue damage, and suppressed colonic myeloperoxidase activity and nitric oxide levels in mice with DSS-induced colitis. Moreover, Pd-Ib greatly suppressed the secretion of pro-inflammatory cytokines TNF-α, IFN-γ, IL-6, and IL-17A while enhancing the level of anti-inflammatory cytokine IL-4. The protein levels of phosphorylated STAT3 (p-STAT3) and phosphorylated p38 (p-p38) were down-regulated in the colonic tissues of DSS-treated mice. Importantly, the anti-inflammatory effect of Pd-Ib against acute colitis was comparable to the anti-inflammatory sulfa drug sulfasalazine (300 mg/kg). Furthermore, the in vitro study showed that the inhibitory effect of Pd-Ib on p-STAT3 and IL-6 protein levels was accompanied by the reduction of MAPKs (JNK and p38). In conclusion, this study suggested that Pd-Ib attenuated DSS-induced acute colitis via the regulation of interleukins principally through the STAT3 and MAPK pathways.


Subject(s)
Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Bupleurum/chemistry , Colitis/chemically induced , Coumarins/isolation & purification , Coumarins/pharmacology , Dextran Sulfate/adverse effects , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/chemistry , Colon/drug effects , Coumarins/administration & dosage , Coumarins/chemistry , Cytokines/metabolism , Disease Models, Animal , Interleukin-17/therapeutic use , Interleukin-4/metabolism , Interleukin-6/metabolism , Macrophages/drug effects , Male , Mice , Mice, Inbred C57BL , Mitogen-Activated Protein Kinase Kinases/drug effects , Molecular Structure , NF-kappa B/antagonists & inhibitors , Nitric Oxide Synthase Type II/metabolism , STAT3 Transcription Factor/drug effects , Stereoisomerism , Sulfasalazine/pharmacology
13.
Chin Med ; 11: 5, 2016.
Article in English | MEDLINE | ID: mdl-26877763

ABSTRACT

BACKGROUND: This study aims to identify the major anti-inflammatory components in the petroleum ether extract of Bupleurum malconense (Chaihu), by bioassay-guided fractionation, and to investigate the anti-inflammatory mechanisms of active components in lipopolysaccharide (LPS)-stimulated murine macrophage RAW-Blue cells. METHODS: A QUANTI-Blue assay was used to guide fractionation of B. malconense root extract. The petroleum ether extract which exerted significant secreted embryonic alkaline phosphatase (SEAP) inhibition effect was purified by silica gel column chromatography and assisted with reverse phase HPLC. The major bioactive compound which significantly inhibited SEAP activity was obtained and its anti-inflammatory effects in LPS-induced RAW-Blue cells were measured by the overproduction of NO (Griess method), gene expression of Il-1ß, Tnf-α and iNos (real-time PCR). In parallel, protein expressions of COX-2, iNOS and IκB-α were determined by western blot. RESULTS: In bioassay-guided fractionation using LPS-stimulated mouse macrophage RAW-Blue cells, (+)-3'-angeloxyloxy-4'-keto-3',4'-dihydroseselin (Pd-Ib) was identified by MS and NMR spectral analyses. Pd-Ib (5, 10, 20 µg/mL) suppressed the gene expression of Il-1ß (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations), Tnf-α (P = 0.006, P = 0.001, P < 0.0001 for three respective concentrations) and iNos (P = 0.009, P < 0.0001, P < 0.0001 for three respective concentrations) in LPS-stimulated macrophages. The production of cyclooxygenase-2 (P = 0.019, P = 0.002, P < 0.0001), iNOS (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) and NO (P < 0.0001, P < 0.0001, P < 0.0001 for three respective concentrations) significantly decreased when macrophages were treated with Pd-Ib (5, 10, 20 µg/mL) in the presence of LPS. Pd-Ib (5, 10, 20 µg/mL) suppressed the nuclear activation of NF-κB while it up-regulated the IκB-α level (P = 0.028, P = 0.013, P = 0.005 for three respective concentrations) in LPS-stimulated macrophages. CONCLUSIONS: Pd-Ib isolated from B. malconense suppressed LPS-induced inflammatory responses in macrophages by inhibiting NF-κB activity and reducing the expression of iNOS, COX-2 as well as pro-inflammatory cytokines.

14.
Zhongguo Zhong Yao Za Zhi ; 41(23): 4314-4319, 2016 Dec.
Article in Chinese | MEDLINE | ID: mdl-28933105

ABSTRACT

Diabetes mellitus is a characterized by high blood sugar metabolic disease, is a lifelong disease with a high incidence of major hazards. Prevention and treatment of diabetes and its complications has become a serious challenge and arduous task facing the world pharmaceutical researchers. Oxidative stress, Nfr2-NF-κB signaling axis related epigenomic genes have the apparent close relationship with type 2 diabetes,those have become one of the key focus and effective way to explore its pathogenesis, mechanism and drug screening. This paper systematically summarizes the current stage research regulating the key proteins, mRNA about Nrf2-NF-κB axis pathway and epigenomics for treatment of type 2 diabetes and the mechanism of traditional Chinese medicine and natural medicine (component) in the treatment of type 2 diabetes, hoping to provide some innovative research ideas for finding new drugs of the treatment of diabetes from traditional Chinese medicine and natural medicine.


Subject(s)
Diabetes Mellitus, Type 2/therapy , Epigenesis, Genetic , Medicine, Chinese Traditional , NF-E2-Related Factor 2/metabolism , NF-kappa B/metabolism , Humans
15.
Sci Rep ; 5: 12095, 2015 Jul 10.
Article in English | MEDLINE | ID: mdl-26160593

ABSTRACT

A novel neuropeptide spexin was found to be broadly expressed in various endocrine and nervous tissues while little is known about its functions. This study investigated the role of spexin in bowel movement and the underlying mechanisms. In functional constipation (FC) patients, serum spexin levels were significantly decreased. Consistently, in starved mice, the mRNA of spexin was significantly decreased in intestine and colon. Spexin injection increased the velocity of carbon powder propulsion in small intestine and decreased the glass beads expulsion time in distal colon in mice. Further, spexin dose-dependently stimulated the intestinal/colonic smooth muscle contraction. Galanin receptor 2 (GALR2) antagonist M871, but not Galanin receptor 3 (GALR3) antagonist SNAP37899, effectively suppressed the stimulatory effects of spexin on intestinal/colonic smooth muscle contraction, which could be eliminated by extracellular [Ca(2+)] removal and L-type voltage-dependent Ca(2+) channel (VDCC) inhibitor nifedipine. Besides, spexin dramatically increased the [Ca(2+)]i in isolated colonic smooth muscle cells. These data indicate that spexin can act on GALR2 receptor to regulate bowel motility by activating L-type VDCC. Our findings provide evidence for important physiological roles of spexin in GI functions. Selective action on spexin pathway might have therapeutic effects on GI diseases with motility disorders.


Subject(s)
Calcium Channels, L-Type/metabolism , Constipation/metabolism , Gastrointestinal Transit/physiology , Peptide Hormones/metabolism , Receptor, Galanin, Type 2/metabolism , Animals , Calcium/metabolism , Case-Control Studies , Colon/drug effects , Colon/metabolism , Constipation/drug therapy , Female , Gastrointestinal Transit/drug effects , Humans , Indoles/therapeutic use , Male , Mice , Mice, Inbred C57BL , Middle Aged , Muscle Contraction/drug effects , Myocytes, Smooth Muscle/drug effects , Myocytes, Smooth Muscle/metabolism , Neuropeptides/metabolism , Nifedipine/therapeutic use , Peptides/therapeutic use , Receptor, Galanin, Type 2/antagonists & inhibitors , Receptor, Galanin, Type 3/antagonists & inhibitors , Receptor, Galanin, Type 3/metabolism
16.
J Nat Prod ; 76(2): 250-5, 2013 Feb 22.
Article in English | MEDLINE | ID: mdl-23327759

ABSTRACT

Seven new dibenzocyclooctadiene lignans, marlignans M-S (1-7), four new norlignans, marphenols C-F (8-11), and 21 known compounds (12-32) were isolated from the fruits of Schisandra wilsoniana. The structures of 1-11 were elucidated by spectroscopic methods including 1D- and 2D-NMR techniques and CD experiments. Compounds 1-11 were evaluated for their anti-HIV activities and showed EC(50) values in the range 2.97-6.18 µg/mL and therapeutic index values of 5.33-29.13.


Subject(s)
Anti-HIV Agents/isolation & purification , Cyclooctanes/isolation & purification , Drugs, Chinese Herbal/isolation & purification , Lignans/isolation & purification , Schisandra/chemistry , Anti-HIV Agents/chemistry , Anti-HIV Agents/pharmacology , Cyclooctanes/chemistry , Cyclooctanes/pharmacology , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Fruit/chemistry , HIV-1/drug effects , Lignans/chemistry , Lignans/pharmacology , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular
17.
Chem Pharm Bull (Tokyo) ; 59(11): 1344-7, 2011.
Article in English | MEDLINE | ID: mdl-22041069

ABSTRACT

Four new neolignans, marphenols G-J (1-4), together with two known ones, were isolated from the leaves and stems of Schisandra wilsoniana. The structures of 1-4 were elucidated by spectroscopic methods, including extensive 1D- and 2D-NMR techniques. New compounds 1-4 were tested for their anti-human immunodeficiency virus (HIV)-1 activities and they showed weak bioactivities.


Subject(s)
Anti-HIV Agents/pharmacology , HIV-1/drug effects , Lignans/pharmacology , Schisandra/chemistry , Anti-HIV Agents/chemistry , Anti-HIV Agents/isolation & purification , Humans , Lignans/chemistry , Lignans/isolation & purification , Magnetic Resonance Spectroscopy , Molecular Conformation , Plant Leaves/chemistry , Plant Stems/chemistry
18.
Chem Pharm Bull (Tokyo) ; 59(11): 1421-4, 2011.
Article in English | MEDLINE | ID: mdl-22041084

ABSTRACT

Two new secolignans and one new neolignan, named feddeiphenols A-C (1-3), together with eight known compounds (4-11), were isolated from the leaves and stems of Daphne feddei. Their structures were established on the base of spectroscopic methods, mainly extensive NMR, UV spectroscopy, and MS spectrometry. Compounds 1-11 were tested for their anti-human immunodeficiency virus (HIV)-1 activity and cytotoxicity. The results revealed that compounds 1, 2, 3, 7, and 9 showed therapeutic index (TI) values above 30, respectively, and the other compounds also showed weak anti-HIV-1 activity. Compound 1 showed modest cytotoxic activity. The other compounds also showed weak cytotoxic activity.


Subject(s)
Anti-HIV Agents/chemistry , Anti-HIV Agents/pharmacology , Daphne/chemistry , Lignans/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Anti-HIV Agents/isolation & purification , Cell Line, Tumor , HIV-1/drug effects , Humans , Lignans/isolation & purification , Lignans/toxicity , Magnetic Resonance Spectroscopy , Mass Spectrometry , Molecular Conformation , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Plant Stems/chemistry , Spectrophotometry, Ultraviolet
19.
J Asian Nat Prod Res ; 13(5): 393-9, 2011 May.
Article in English | MEDLINE | ID: mdl-21534036

ABSTRACT

Two new dibenzocyclooctadiene lignans, rubrilignans A and B (1, 2), together with 17 known ones, were isolated from the fruits of Schisandra rubriflora. The structures of 1 and 2 were elucidated by spectroscopic methods including extensive 1D and 2D NMR techniques. Compounds 1 and 2 were also evaluated for their anti-HIV-1 activities and showed weak anti-HIV-1 activity with EC(50) values of 2.26 and 1.82 µg/ml, and therapeutic index values of 35.5 and 18.6, respectively.


Subject(s)
Anti-HIV Agents/isolation & purification , Anti-HIV Agents/pharmacology , Drugs, Chinese Herbal/isolation & purification , Drugs, Chinese Herbal/pharmacology , HIV-1/drug effects , Lignans/isolation & purification , Lignans/pharmacology , Schisandra/chemistry , Anti-HIV Agents/chemistry , Drugs, Chinese Herbal/chemistry , Fruit/chemistry , Lignans/chemistry , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular
20.
Redox Rep ; 14(6): 243-50, 2009.
Article in English | MEDLINE | ID: mdl-20003709

ABSTRACT

Previous studies have reported that selenite, a known antioxidant, protects brain against ischemia/reperfusion injury, which is mediated by oxidative stress. The aim of this study was to investigate whether selenite can protect kidney against ischemic injury by reducing activation of the apoptosis signal regulating kinase 1 (ASK1)/mitogen-activated protein kinase kinase 3 (MKK3)/p38 mitogen-activated protein kinase signaling pathway. The activation and expression of ASK1, MKK3, p38, caspase 3 and cleaved PARP were analyzed by Western blot. Apoptosis of renal tubular epithelial cells was assessed by the terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling method. Malondialdehyde (MDA) levels were measured by the thiobarbituric acid reaction. Blood serum creatinine and blood urea nitrogen level were measured with an Olympus automatic multi-analyzer. We found that selenite attenuated significantly ASK1, MKK3, and p38 phosphorylation at 3 h after renal ischemia. Furthermore, selenite decreased significantly renal epithelial tubular cell apoptosis. In addition, selenite reduced the MDA level. These findings suggest that the protective action of selenite on ischemia renal injury is associated closely with reducing activation of the ASK1-MKK3-p38 signal pathway.


Subject(s)
Kidney/drug effects , MAP Kinase Kinase 3/antagonists & inhibitors , MAP Kinase Kinase Kinase 5/antagonists & inhibitors , Reperfusion Injury/drug therapy , Signal Transduction/drug effects , Sodium Selenite/therapeutic use , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Apoptosis/physiology , Caspase 3/metabolism , Enzyme Activation , Humans , Kidney/metabolism , Kidney/pathology , Lipid Peroxidation/drug effects , MAP Kinase Kinase 3/metabolism , MAP Kinase Kinase Kinase 5/metabolism , Male , Poly(ADP-ribose) Polymerases/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Signal Transduction/physiology , Sodium Selenite/pharmacology , p38 Mitogen-Activated Protein Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...